Health Technology · Medical Specialties · NSE: QLINE · data 2026-10-09
Q-Line Biotech Limited
Health check: Strong (8.8/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹636.2
Market cap
₹1,530 cr
P/E
—
P/B
—
ROE
25.6%
ROCE
27.9%
Debt / equity
0.92
Dividend yield
0.00%
1-year return
40.8%
52-week high
₹735
52-week low
₹431
Operating margin
—
Growth
| Revenue (last 12 months) | — |
| Net profit (last 12 months) | — |
| Sales growth, 3 years (yearly) | 23.2% |
| Profit growth, 3 years (yearly) | 20.2% |
Similar companies
Virtuoso Optoelectronics Limited (VOEPL) · MIC Electronics Limited (MICEL) · Osel Devices Limited (OSELDEVICE) · Nureca Ltd. (NURECA) · Yash Optics and Lens Limited (YASHOPTICS)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open QLINE in NSE Scanner →